Disease | adenocarcinoma |
Phenotype | C0302592|cervical carcinoma |
Sentences | 1 |
PubMedID- 21693061 | We evaluated the expression of tissue factor (tf) in cervical cancer and the potential of hi-con1, an antibody-like-molecule targeted against tf, as a novel form of immunotherapy against multiple primary cervical carcinoma cell lines with squamous- and adenocarcinoma histology. |
Page: 1